Author

Seiji Mori

Morinomiya University of Medical Sciences

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Chao‐Wen ChengiD· 1 shared Chih-Chieh Chang· 1 shared Yoko K. Takada· 1 shared Yoshikazu TakadaiD· 1 shared Yukina Maekawa· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Chao‐Wen ChengORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BiochemistryCellsPeer-reviewedFeb 7, 2024

FGF9, a potent mitogen, is a new ligand for integrin αvβ3, and the FGF9 mutant defective in integrin binding acts as an antagonist.

Chih-Chieh Chang, Yoko K. Takada, Chao‐Wen Cheng…·Yoshikazu Takada

This study identifies FGF9 as a new ligand for integrin αvβ3 and shows that a mutant defective in integrin binding acts as an antagonist by suppressing FGF9 signaling.

4 citations

humanproteomics

𝕏 PostBluesky